‘I believe that validated PET-imaging biomarkers could transform the future clinical cancer care’
The focus of senior consultant Elin Trägårdh’s research is diagnostic nuclear medicine – in particular a modality called PET/CT. It is used mainly for evaluation of patients with cancer. Today, PET/CT is reviewed manually by doctors. ”I think we don't use all the information there is in the images. What if we could use artificial intelligence to help us to quantify the images and obtain as much in
https://www.wcmm.lu.se/article/i-believe-validated-pet-imaging-biomarkers-could-transform-future-clinical-cancer-care - 2025-10-09